P2Y6 Receptor-Mediated Microglial Phagocytosis in Radiation-Induced Brain Injury

Molecular Neurobiology

Volumn 53, Issue 6, 2016, Pages 3552-3564

  Xu, Yongteng ^a   Hu, Weihan ^b   Liu, Yimin ^a   Xu, Pengfei ^a   Li, Zichen ^a   Wu, Rong ^a   Shi, Xiaolei ^a   Tang, Yamei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Microglial phagocytosis; MLCK; Myelin; Neuronal apoptosis; P2Y6 receptor; Rac1; Radiation induced brain injury

Indexed keywords

MYOSIN LIGHT CHAIN KINASE; PROTEIN NOGO A; PURINERGIC P2Y6 RECEPTOR; RAC1 PROTEIN; MLCK PEPTIDE; PEPTIDE; PURINERGIC P2 RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; CELL ACTIVATION; CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; MALE; MICROGLIA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; RADIATION INDUCED BRAIN INJURY; RADIATION INJURY; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; COMPLICATION; HIPPOCAMPUS; METABOLISM; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

ANIMALS; BRAIN INJURIES; HIPPOCAMPUS; MALE; MICE, INBRED BALB C; MICROGLIA; MODELS, BIOLOGICAL; NEURONS; PEPTIDES; PHAGOCYTOSIS; RAC1 GTP-BINDING PROTEIN; RADIATION INJURIES; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84932082758     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9282-3     Document Type: Article

References (45)

1. Welsh LC, Dunlop AW, McGovern T, McQuaid D, Dean JA, Gulliford SL, Bhide SA, Harrington KJ et al (2014) Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin Oncol 26(12):765–775. doi:10.1016/j.clon.2014.06.014
2. Ampil FL, Kim DD, Ghali GE, Baluna RG (2012) How intensive should radiotherapy for head and neck cancer with synchronous distant metastases be? Review of cases. J Oral Maxillofacl Surg: Off J Am Assoc Oral Maxillofac Surg 70(3):730–733. doi:10.1016/j.joms.2011.03.037
3. Butler JM, Rapp SR, Shaw EG (2006) Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options in Oncol 7(6):517–523
4. McIver JI, Pollock BE (2004) Radiation-induced tumor after stereotactic radiosurgery and whole brain radiotherapy: case report and literature review. J Neuro-Oncol 66(3):301–305
5. Dietrich J, Monje M, Wefel J, Meyers C (2008) Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist 13(12):1285–1295
6. Wang YX, King AD, Zhou H, Leung SF, Abrigo J, Chan YL, Hu CW, Yeung DK et al (2010) Evolution of radiation-induced brain injury: MR imaging-based study. Radiology 254(1):210–218
7. Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD (2012) Radiation-induced brain injury: a review. Front Oncol 2:73. doi:10.3389/fonc.2012.00073
8. Shaw EG, Robbins ME (2006) The management of radiation-induced brain injury. Cancer Treat Res 128:7–22
9. Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304(1):1–7. doi:10.1124/jpet.102.035048
10. Gonzalez-Scarano F, Baltuch G (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22:219–240. doi:10.1146/annurev.neuro.22.1.219
11. Choi DK, Koppula S, Suk K (2011) Inhibitors of microglial neurotoxicity: focus on natural products. Molecules 16(2):1021–1043. doi:10.3390/molecules16021021
12. Fu R, Shen Q, Xu P, Luo JJ, Tang Y (2014) Phagocytosis of microglia in the central nervous system diseases. Mol Neurobiol 49(3):1422–1434. doi:10.1007/s12035-013-8620-6
13. Kotter MR, Li WW, Zhao C, Franklin RJ (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci: Off J Soc Neurosci 26(1):328–332. doi:10.1523/JNEUROSCI.2615-05.2006
14. Brown GC, Neher JJ (2014) Microglial phagocytosis of live neurons. Nat Rev Neurosci 15(4):209–216. doi:10.1038/nrn3710
15. Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, Jin J, Fernandez F, Tan J et al (2011) Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain 4(1):23. doi:10.1186/1756-6606-4-23
16. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17(7):796–808. doi:10.1038/nm.2399
17. Peng Y, Lu K, Li Z, Zhao Y, Wang Y, Hu B, Xu P, Shi X et al (2014) Blockade of Kv1.3 channels ameliorates radiation-induced brain injury. Neuro-Oncology 16(4):528–539. doi:10.1093/neuonc/not221
18. Panagiotakos G, Alshamy G, Chan B, Abrams R, Greenberg E, Saxena A, Bradbury M, Edgar M et al (2007) Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS One 2(7):e588. doi:10.1371/journal.pone.0000588
19. Olschowka JA, Kyrkanides S, Harvey BK, O’Banion MK, Williams JP, Rubin P, Hansen JT (1997) ICAM-1 induction in the mouse CNS following irradiation. Brain Behav Immun 11(4):273–285. doi:10.1006/brbi.1997.0506
20. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA et al (2007) UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446(7139):1091–1095. doi:10.1038/nature05704
21. Niedergang F, Chavrier P (2005) Regulation of phagocytosis by Rho GTPases. Curr Top Microbiol Immunol 291:43–60
22. Gitik M, Reichert F, Rotshenker S (2010) Cytoskeleton plays a dual role of activation and inhibition in myelin and zymosan phagocytosis by microglia. FASEB J: Off Publ Fed Am Soc Exp Biol 24(7):2211–2221. doi:10.1096/fj.09-146118
23. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y (2004) Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A 101(20):7618–7623. doi:10.1073/pnas.0307512101
24. Dubois-Dalcq M, Ffrench-Constant C, Franklin RJ (2005) Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48(1):9–12. doi:10.1016/j.neuron.2005.09.004
25. Franklin RJ, Kotter MR (2008) The biology of CNS remyelination: the key to therapeutic advances. J Neurol 255(Suppl 1):19–25. doi:10.1007/s00415-008-1004-6
26. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101(4):890–898. doi:10.1172/JCI1112
27. Neher JJ, Neniskyte U, Hornik T, Brown GC (2014) Inhibition of UDP/P2Y6 purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo. Glia 62(9):1463–1475. doi:10.1002/glia.22693
28. Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76(2):77–98. doi:10.1016/j.pneurobio.2005.06.004
29. Rock RB, Peterson PK (2006) Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimmune Pharmacol: Off J Soc NeuroImmune Pharmacol 1(2):117–126. doi:10.1007/s11481-006-9012-8
30. Greter M, Merad M (2013) Regulation of microglia development and homeostasis. Glia 61(1):121–127. doi:10.1002/glia.22408
31. Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158(3):1021–1029
32. Ravichandran KS (2011) Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 35(4):445–455. doi:10.1016/j.immuni.2011.09.004
33. Inoue K (2007) UDP facilitates microglial phagocytosis through P2Y6 receptors. Cell Adhes Migr 1(3):131–132
34. Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP (2009) Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158(3):1007–1020. doi:10.1016/j.neuroscience.2008.07.067
35. Hanke ML, Kielian T (2011) Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci 121(9):367–387. doi:10.1042/CS20110164
36. Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V, Konig J, Lehrach H et al (2007) TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun 359(3):574–579. doi:10.1016/j.bbrc.2007.05.157
37. Sierra A, Abiega O, Shahraz A, Neumann H (2013) Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci 7:6. doi:10.3389/fncel.2013.00006
38. Yiu G, He Z (2006) Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7(8):617–627. doi:10.1038/nrn1956
39. Boekhoff TM, Ensinger EM, Carlson R, Bock P, Baumgartner W, Rohn K, Tipold A, Stein VM (2012) Microglial contribution to secondary injury evaluated in a large animal model of human spinal cord trauma. J Neurotrauma 29(5):1000–1011. doi:10.1089/neu.2011.1821
40. Cullheim S, Thams S (2007) The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res Rev 55(1):89–96. doi:10.1016/j.brainresrev.2007.03.012
41. Bose S, Cho J (2013) Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Arch Pharm Res 36(9):1039–1050. doi:10.1007/s12272-013-0161-z
42. Faustino JV, Wang X, Johnson CE, Klibanov A, Derugin N, Wendland MF, Vexler ZS (2011) Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci: Off J Soc Neurosci 31(36):12992–13001. doi:10.1523/JNEUROSCI.2102-11.2011
43. Lee CY, Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm 117(8):949–960. doi:10.1007/s00702-010-0433-4
44. Satoh J, Tabunoki H, Ishida T, Yagishita S, Jinnai K, Futamura N, Kobayashi M, Toyoshima I et al (2012) Phosphorylated Syk expression is enhanced in Nasu-Hakola disease brains. Neuropathol: Off J Jpn Soc Neuropathol 32(2):149–157. doi:10.1111/j.1440-1789.2011.01256.x
45. Kataoka A, Koga Y, Uesugi A, Tozaki-Saitoh H, Tsuda M, Inoue K (2011) Involvement of vasodilator-stimulated phosphoprotein in UDP-induced microglial actin aggregation via PKC- and Rho-dependent pathways. Purinergic Signal 7(4):403–411. doi:10.1007/s11302-011-9237-8